Wuppertal, Germany

Christoph Freiberg

USPTO Granted Patents = 14 

 

 

Average Co-Inventor Count = 8.5

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2002-2024

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):

Title: Christoph Freiberg: Innovator in Antibody Development

Introduction

Christoph Freiberg is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 14 patents to his name, Freiberg's work has the potential to impact cancer treatment and other medical conditions.

Latest Patents

One of Freiberg's latest patents is focused on Anti-CEACAM6 antibodies and their uses. This invention provides recombinant antigen-binding regions and antibodies that are specific for human CEACAM6, a molecule associated with various cancers. The antibodies developed through this invention do not significantly cross-react with closely related human CEACAM proteins, making them a targeted therapeutic option. The patent also outlines methods for generating these antibodies, as well as nucleic acid sequences, vectors, pharmaceutical compositions, and kits for their use.

Career Highlights

Freiberg has worked with prominent companies in the pharmaceutical industry, including Bayer Intellectual Property GmbH and Bayer Healthcare Aktiengesellschaft. His experience in these organizations has allowed him to refine his expertise in patent development and biotechnology.

Collaborations

Some of his notable coworkers include Andreas Wilmen and Mark Trautwein. Their collaboration has likely contributed to the innovative advancements in antibody research and development.

Conclusion

Christoph Freiberg's contributions to the field of biotechnology, particularly through his patents on Anti-CEACAM6 antibodies, highlight his role as a significant inventor. His work continues to pave the way for advancements in cancer treatment and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…